AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company ...
People also ask
Is ABBV stock a buy or sell?
What is the future of ABBV stock?
Is AbbVie still owned by Abbott?
Is AbbVie overvalued?
ABBV | Complete AbbVie Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
$161.98
Get the latest AbbVie Inc (ABBV) real-time quote ... NYSE · Disclaimer. 1D. 5D. 1M. 6M. YTD. 1Y ... AbbVie Inc. is an American pharmaceutical company headquartered ...
Discover real-time AbbVie Inc. Common Stock (ABBV) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
The current price of ABBV is 160.75 USD — it has increased by 0.22% in the past 24 hours. Watch AbbVie Inc. stock price performance more closely on the chart.
People also search for
AbbVie (NYSE: ABBV). $160.75. (0.2%). $0.35. Price as of May 10, 2024 ...
AbbVie stock price quote (NYSE: ABBV), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.
AbbVie Inc ABBV:NYSE ; Close. 160.75 quote price arrow up +0.35 (+0.22%) ; Volume. 3,235,491 ; 52 week range. 130.96 - 182.89 ...
Rating
(8)
AbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition. 15d ago ... AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share. 27d ago. CVS · SPX.